Alibaba (NYSE: BABA) HR chief reports multi-million share and RSU stake
Rhea-AI Filing Summary
Alibaba Group Holding Ltd’s Chief People Officer, Jiang Fang, has filed an initial statement of ownership showing a substantial equity position. She holds 5,534,168 Ordinary Shares directly and an additional 23,116,864 Ordinary Shares indirectly through a trust. The filing also lists several outstanding unvested restricted share unit awards over Ordinary Shares, including blocks such as 56,000, 42,672, 31,600, and others that vest in scheduled annual or quarterly installments starting between 2021 and 2025. In addition, she holds an option over 160,000 Ordinary Shares expiring on February 24, 2031 with an exercise price of HK$68 (approximately US$8.72) per ordinary share. Some awards were granted in the form of ADSs, where each ADS represents 8 ordinary shares, and each restricted share unit gives a contingent right to receive one ADS or one ordinary share, as applicable.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Restricted Shares Units | -- | -- | -- |
| holding | Restricted Shares Units | -- | -- | -- |
| holding | Restricted Shares Units | -- | -- | -- |
| holding | Restricted Shares Units | -- | -- | -- |
| holding | Restricted Shares Units | -- | -- | -- |
| holding | Restricted Shares Units | -- | -- | -- |
| holding | Restricted Shares Units | -- | -- | -- |
| holding | Option (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Footnotes (11)
- F1. Reflects the outstanding unvested portion of a restricted share unit award granted in the form of American Depository Shares ("ADSs") that vests in six equal annual installments beginning on Apr 1, 2021, subject to the terms and conditions of the underlying award agreement.
- F2. Each restricted share unit represents a contingent right to receive one ADS. Each ADS represents 8 ordinary shares. This amount represents the ordinary shares underlying the ADSs in this award.
- F3. Reflects the outstanding unvested portion of a restricted share unit award granted in the form of ADSs that vests in six equal annual installments beginning on Apr 1, 2022, subject to the terms and conditions of the underlying award agreement.
- F4. Reflects the outstanding unvested portion of a restricted share unit award granted in the form of ADSs that vests in six equal annual installments beginning on Apr 1, 2023, subject to the terms and conditions of the underlying award agreement.
- F5. Reflects the outstanding unvested portion of a restricted share unit award granted in the form of ADSs that vests in six equal annual installments beginning on Apr 1, 2024, subject to the terms and conditions of the underlying award agreement.
- F6. Reflects the outstanding unvested portion of a restricted share unit award granted in the form of ADSs that vests in twenty-four equal quarterly installments beginning on Jul 1, 2024, subject to the terms and conditions of the underlying award agreement.
- F7. Reflects the outstanding unvested portion of a restricted share unit award granted in the form of ordinary shares that vests in twenty-one quarterly installments, with 1/6 vesting on Jul 1, 2025 and 1/24 quarterly thereafter beginning on Oct 1, 2025, subject to the terms and conditions of the underlying award agreement
- F8. Each restricted share unit represents a contingent right to receive one ordinary share.
- F9. Reflects the outstanding unvested portion of a restricted share unit award granted in the form of ordinary shares that vests in twenty-four equal quarterly installments on beginning on Jul 1, 2025, subject to the terms and conditions of the underlying award agreement.
- F10. Reflects an option award granted in the form of ordinary shares that vests 40% in the second year and then 30% each in the third year and the fourth year beginning on Mar 1, 2027, subject to the terms and conditions of the underlying award agreement.
- F11. The exercise price of this option is HK$68 per ordinary share. The exercise price reported herein was converted from Hong Kong dollars to United States dollars at a conversion price of HK$68 to US$8.72.
AI-generated analysis. How Rhea-AI works. Not financial advice.